Product Name: R306465
Description: R306465, also known as JNJ-16241199, is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models. R306465 was found to be a potent inhibitor
CAS NO: 67330-25-0 Product: Ufenamate
Synonym: R 306465; R306465; R-306465; JNJ16241199; JNJ-16241199; JNJ 16241199.
IUPAC Chemical Name: N-hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide
In ChiKey: PPAR inhibitors
SMILE Code: O=C(C1=CN=C(N2CCN(S(=O)(C3=CC=C4C=CC=CC4=C3)=O)CC2)N=C1)NO
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22142838
Chemical Formula：C19H19N5O4S
ExactMass: 413.11
Molecular Weight: 413.45026
Elemental Analysis: C, 55.19; H, 4.63; N, 16.94; O, 15.48; S, 7.76
bet-bromodomain.com
BET Bromodomain Inhibitor
